Browsing by Author Pollock, Bruce G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)
2012Cholinergic pathways and cognition in patients with schizophrenia : a pilot studyRajji, Tarek K.; Chow, Tiffany W.; Voineskos, Aristotle N.; Links, Kira A.; Miranda, Dielle; Mamo, David; Ismail, Zahinoor; Pollock, Bruce G.; Mulsant, Benoit H.
2010Clozapine and global cognition in schizophreniaRajji, Tarek K.; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo, David; Remington, Gary; Pollock, Bruce G.; Mulsant, Benoit H.
2009Clozapine exposure and the impact of smoking and gender : a population pharmacokinetic studyNg, Wenzie; Uchida, Hiroyuki; Ismail, Zahinoor; Mamo, David; Rajji, Tarek K.; Remington, Gary; Sproule, Beth A.; Pollock, Bruce G.; Mulsant, Benoit H.; Bies, Robert R.
2009D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaUchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David
2012Delineating the functional neuroanatomy of illness denial or anosognosia in schizophreniaGerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh
2015Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trialNakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel
2012Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE dataSakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2012Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional studyMizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2013Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET studySuzuki, Takefumi; Graff-Guerrero, Ariel; Uchida, Hiroyuki; Remington, Gary; Caravaggio, Fernando; Borlido, Carol; Pollock, Bruce G.; Mulsant, Benoit H.; Deluca, Vincenzo; Ismail, Zahinoor; Mamo, David
2011Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume correctionsUchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel
2013Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE dataMoriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2013Frontotemporoparietal asymmetry and lack of illness awareness in schizophreniaGerretsen, Philip; Chakravarty, M. Mallar; Mamo, David; Menon, Mahesh; Pollock, Bruce G.; Rajji, Tarek K.; Graff-Guerrero, Ariel
2013Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia : analysis of the CATIE dataTsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel; Mimura, Masaru; Uchida, Hiroyuki
2015Illness denial in schizophrenia spectrum disorders : a function of left hemisphere dominanceGerretsen, Philip; Menon, Mahesh; Chakravarty, M. Mallar; Lerch, Jason P.; Mamo, David; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel
2014Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders : resting state functional connectivityGerretsen, Philip; Menon, Mahesh; Mamo, David; Fervaha, Gagan; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel
2009An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18 F] FP-TZTPvan Oosten, Erik M.; Wilson, Alan A.; Stephenson, Karin A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Yudin, Andrei K.; Houle, Sylvain; Vasdev, Neil
2009The intersection of pharmacology, imaging, and genetics in the development of personalized medicineGerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G.
2010Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F] setoperone PET studyGerretsen, Philip; Graff-Guerrero, Ariel; Menon, Mahesh; Pollock, Bruce G.; Kapur, Shitij; Vasdev, Neil; Houle, Sylvain; Mamo, David
2016Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia : a positron emission tomography dopamine D2/3 receptor occupancy studyFervaha, Gagan; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Pollock, Bruce G.; Nakajima, Shinichiro; Gerretsen, Philip; Rajji, Tarek K.; Mar, Wanna; Iwata, Yusuke; Plitman, Eric; Chung, Jun Ku; Remington, Gary; Graff-Guerrero, Ariel
2009Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychoticsUchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David